Pfiz­er brings on­col­o­gy R&D leader in­to C-suite, parts ways with de­vel­op­ment chief William Pao af­ter just 16 months

Pfiz­er will shuf­fle its ex­ec­u­tive team, em­pha­siz­ing the role on­col­o­gy will play in its fu­ture by adding a new C-suite mem­ber but al­so part­ing ways with its de­vel­op­ment chief just 16 months af­ter poach­ing him from Roche.

William Pao will de­part “in the month ahead,” the New York Big Phar­ma said in a sur­prise move Thurs­day morn­ing. Pfiz­er re­cruit­ed him from Roche’s ex­ec­u­tive bench last year to re­place three-decade vet­er­an Rod MacKen­zie.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER